BNP Paribas Financial Markets’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1
| Closed | -$1 | – | 4077 |
|
|
2023
Q2 | $1 | Hold |
1
| – | – | ﹤0.01% | 3914 |
|
|
2023
Q1 | $1 | Sell |
1
-1,467
| -100% | -$1.19K | ﹤0.01% | 3841 |
|
|
2022
Q4 | $1.2K | Buy |
1,468
+996
| +211% | +$982 | ﹤0.01% | 3782 |
|
|
2022
Q3 | $491 | Sell |
472
-16,374
| -97% | -$26.2K | ﹤0.01% | 4520 |
|
|
2022
Q2 | $27.6K | Buy |
16,846
+13,727
| +440% | +$28.5K | ﹤0.01% | 3663 |
|
|
2022
Q1 | $9.17K | Sell |
3,119
-7,128
| -70% | -$25K | ﹤0.01% | 3815 |
|
|
2021
Q4 | $49K | Buy |
10,247
+2,029
| +25% | +$13.1K | ﹤0.01% | 3741 |
|
|
2021
Q3 | $62.2K | Buy |
8,218
+4,715
| +135% | +$30.2K | ﹤0.01% | 3449 |
|
|
2021
Q2 | $26.1K | Buy |
+3,503
| New | +$27K | ﹤0.01% | 3468 |
|
|
2020
Q3 | – | Sell |
-4
| Closed | -$26 | – | 4315 |
|
|
2020
Q2 | $26 | Sell |
4
-61
| -94% | -$220 | ﹤0.01% | 4244 |
|
|
2020
Q1 | $122 | Hold |
65
| – | – | ﹤0.01% | 4207 |
|
|
2019
Q4 | $122 | Sell |
65
-1,364
| -95% | -$2.27K | ﹤0.01% | 4323 |
|
|
2019
Q3 | $2.03K | Hold |
1,429
| – | – | ﹤0.01% | 4358 |
|
|
2019
Q2 | $4.03K | Sell |
1,429
-1,089
| -43% | -$4.33K | ﹤0.01% | 4265 |
|
|
2019
Q1 | $12K | Buy |
2,518
+2,389
| +1,852% | +$11.8K | ﹤0.01% | 4004 |
|
|
2018
Q4 | $547 | Sell |
129
-109
| -46% | -$842 | ﹤0.01% | 3998 |
|
|
2018
Q3 | $2.6K | Buy |
+238
| New | +$2.79K | ﹤0.01% | 4226 |
|
BNP Paribas Financial Markets's SURF Position: Q3 2023 in Review
BNP Paribas Financial Markets sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 1 share — an estimated $1 sold.
BNP Paribas Financial Markets first reported a position in SURF in Q3 2018 and held it in 17 quarters. The position peaked at $62.2K in Q3 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.
- BNP Paribas Financial Markets reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- BNP Paribas Financial Markets sold 1 Surface Oncology, Inc. Common Stock share in Q3 2023, an estimated $1.
- BNP Paribas Financial Markets first reported a position in Surface Oncology, Inc. Common Stock in Q3 2018 and held it in 17 quarters.
- BNP Paribas Financial Markets's Surface Oncology, Inc. Common Stock position peaked at $62.2K in Q3 2021.
- 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2023, filed 14 Nov 2023.